Study To Investigate Safety And Efficacy Of Sildenafil In The Newborns With Persistent Pulmonary Hypertension (PPHN)

NCT01069861 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

4

Enrollment

INDUSTRY

Sponsor class

Stopped See termination reason in detailed description.

Conditions

PPHN
Persistent Pulmonary Hypertension of the Newborn
Hypoxic Respiratory Failure

Interventions

DRUG: sildanefil

Sponsor

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.